Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $776.08 million. The enterprise value is $183.22 million.
| Market Cap | 776.08M |
| Enterprise Value | 183.22M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 63.82 million shares outstanding. The number of shares has increased by 44.64% in one year.
| Shares Outstanding | 63.82M |
| Shares Change (YoY) | +44.64% |
| Shares Change (QoQ) | +22.57% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 111.99% |
| Float | 47.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,694.73 |
| Forward PS | 2,189.79 |
| PB Ratio | 1.33 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 636.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.99, with a Debt / Equity ratio of 0.03.
| Current Ratio | 23.99 |
| Quick Ratio | 23.47 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -95.13 |
Financial Efficiency
Return on equity (ROE) is -53.70% and return on invested capital (ROIC) is -39.46%.
| Return on Equity (ROE) | -53.70% |
| Return on Assets (ROA) | -48.40% |
| Return on Capital (ROIC) | -39.46% |
| Revenue Per Employee | $3,064 |
| Profits Per Employee | -$2.32M |
| Employee Count | 94 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.77% in the last 52 weeks. The beta is 1.06, so VRDN's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -50.77% |
| 50-Day Moving Average | 13.14 |
| 200-Day Moving Average | 16.25 |
| Relative Strength Index (RSI) | 44.04 |
| Average Volume (20 Days) | 1,211,858 |
Short Selling Information
The latest short interest is 9.39 million, so 14.72% of the outstanding shares have been sold short.
| Short Interest | 9.39M |
| Short Previous Month | 9.65M |
| Short % of Shares Out | 14.72% |
| Short % of Float | 19.67% |
| Short Ratio (days to cover) | 9.81 |
Income Statement
In the last 12 months, VRDN had revenue of $288,000 and -$218.13 million in losses. Loss per share was -$4.49.
| Revenue | 288,000 |
| Gross Profit | 288,000 |
| Operating Income | -237.87M |
| Pretax Income | -218.13M |
| Net Income | -218.13M |
| EBITDA | -215.27M |
| EBIT | -215.86M |
| Loss Per Share | -$4.49 |
Balance Sheet
The company has $613.19 million in cash and $20.33 million in debt, giving a net cash position of $592.86 million or $9.29 per share.
| Cash & Cash Equivalents | 613.19M |
| Total Debt | 20.33M |
| Net Cash | 592.86M |
| Net Cash Per Share | $9.29 |
| Equity (Book Value) | 582.53M |
| Book Value Per Share | 9.13 |
| Working Capital | 600.69M |
Cash Flow
In the last 12 months, operating cash flow was -$167.42 million and capital expenditures -$783,000, giving a free cash flow of -$168.20 million.
| Operating Cash Flow | -167.42M |
| Capital Expenditures | -783,000 |
| Free Cash Flow | -168.20M |
| FCF Per Share | -$2.75 |
Margins
Gross margin is 100.00%, with operating and profit margins of -82,595.14% and -75,737.85%.
| Gross Margin | 100.00% |
| Operating Margin | -82,595.14% |
| Pretax Margin | -75,737.85% |
| Profit Margin | -75,737.85% |
| EBITDA Margin | -74,747.92% |
| EBIT Margin | -74,950.00% |
| FCF Margin | -58,403.82% |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.64% |
| Shareholder Yield | -44.64% |
| Earnings Yield | -28.11% |
| FCF Yield | -21.67% |
Analyst Forecast
The average price target for VRDN is $31.56, which is 159.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $31.56 |
| Price Target Difference | 159.54% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 381.74% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 8.03 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.03 |
| Piotroski F-Score | 2 |